Annual CFF
$14.47 M
+$9.51 M+191.84%
31 December 2023
Summary:
Cytosorbents annual cash flow from financing activities is currently $14.47 million, with the most recent change of +$9.51 million (+191.84%) on 31 December 2023. During the last 3 years, it has fallen by -$51.87 million (-78.18%). CTSO annual CFF is now -78.18% below its all-time high of $66.35 million, reached on 31 December 2020.CTSO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$99.00 K
-$9.93 M-101.01%
30 September 2024
Summary:
Cytosorbents quarterly cash flow from financing activities is currently -$99.00 thousand, with the most recent change of -$9.93 million (-101.01%) on 30 September 2024. Over the past year, it has dropped by -$747.30 thousand (-115.27%). CTSO quarterly CFF is now -100.18% below its all-time high of $56.38 million, reached on 30 September 2020.CTSO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$21.37 M
-$747.30 K-3.38%
30 September 2024
Summary:
Cytosorbents TTM cash flow from financing activities is currently $21.37 million, with the most recent change of -$747.30 thousand (-3.38%) on 30 September 2024. Over the past year, it has increased by +$14.11 million (+194.26%). CTSO TTM CFF is now -74.02% below its all-time high of $82.27 million, reached on 30 September 2020.CTSO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +191.8% | -115.3% | +194.3% |
| 3 y3 years | -78.2% | -116.8% | +248.9% |
| 5 y5 years | -17.1% | -101.9% | +171.2% |
CTSO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -78.2% | +1923.8% | -100.8% | +82.7% | -3.4% | +248.9% |
| 5 y | 5 years | -78.2% | +1923.8% | -100.2% | +99.3% | -74.0% | +248.9% |
| alltime | all time | -78.2% | -100.2% | +99.3% | -74.0% | +248.9% |
Cytosorbents Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$99.00 K(-101.0%) | $21.37 M(-3.4%) |
| June 2024 | - | $9.83 M(-1819.9%) | $22.12 M(+67.4%) |
| Mar 2024 | - | -$571.80 K(-104.7%) | $13.22 M(-8.7%) |
| Dec 2023 | $14.47 M(+191.8%) | $12.21 M(+1783.5%) | $14.47 M(+99.3%) |
| Sept 2023 | - | $648.30 K(-30.4%) | $7.26 M(+9.8%) |
| June 2023 | - | $931.10 K(+36.1%) | $6.62 M(+16.4%) |
| Mar 2023 | - | $684.30 K(-86.3%) | $5.68 M(+14.6%) |
| Dec 2022 | $4.96 M(+593.5%) | $5.00 M(>+9900.0%) | $4.96 M(-4188.7%) |
| Sept 2022 | - | $0.00(0.0%) | -$121.30 K(-125.9%) |
| June 2022 | - | $0.00(-100.0%) | $468.40 K(-21.7%) |
| Mar 2022 | - | -$40.40 K(-50.1%) | $598.30 K(-16.4%) |
| Dec 2021 | $715.20 K(-98.9%) | -$80.90 K(-113.7%) | $715.30 K(-105.0%) |
| Sept 2021 | - | $589.70 K(+354.0%) | -$14.35 M(-134.6%) |
| June 2021 | - | $129.90 K(+69.6%) | $41.44 M(-14.6%) |
| Mar 2021 | - | $76.60 K(-100.5%) | $48.54 M(-26.8%) |
| Dec 2020 | $66.35 M(+711.3%) | -$15.15 M(-126.9%) | $66.35 M(-19.4%) |
| Sept 2020 | - | $56.38 M(+679.4%) | $82.27 M(+164.5%) |
| June 2020 | - | $7.23 M(-59.5%) | $31.11 M(+29.3%) |
| Mar 2020 | - | $17.88 M(+2213.9%) | $24.05 M(+194.1%) |
| Dec 2019 | $8.18 M(-53.2%) | $772.80 K(-85.2%) | $8.18 M(+3.8%) |
| Sept 2019 | - | $5.22 M(+2796.9%) | $7.88 M(+50.7%) |
| June 2019 | - | $180.20 K(-91.0%) | $5.23 M(-59.9%) |
| Mar 2019 | - | $2.00 M(+321.6%) | $13.03 M(-25.4%) |
| Dec 2018 | $17.47 M(-13.2%) | $475.50 K(-81.5%) | $17.47 M(-12.2%) |
| Sept 2018 | - | $2.57 M(-67.8%) | $19.90 M(+4.6%) |
| June 2018 | - | $7.98 M(+23.8%) | $19.02 M(-27.9%) |
| Mar 2018 | - | $6.44 M(+121.6%) | $26.39 M(+31.1%) |
| Dec 2017 | $20.12 M(+297.4%) | $2.91 M(+72.1%) | $20.12 M(+16.5%) |
| Sept 2017 | - | $1.69 M(-89.0%) | $17.27 M(+10.1%) |
| June 2017 | - | $15.35 M(+8606.6%) | $15.68 M(+200.8%) |
| Mar 2017 | - | $176.30 K(+232.6%) | $5.21 M(+2.9%) |
| Dec 2016 | $5.06 M(-56.5%) | $53.00 K(-47.6%) | $5.06 M(-9.7%) |
| Sept 2016 | - | $101.20 K(-97.9%) | $5.61 M(-7.7%) |
| June 2016 | - | $4.88 M(>+9900.0%) | $6.07 M(+266.7%) |
| Mar 2016 | - | $27.90 K(-95.3%) | $1.66 M(-85.8%) |
| Dec 2015 | $11.64 M | $596.10 K(+5.0%) | $11.64 M(+3.8%) |
| Sept 2015 | - | $567.90 K(+22.3%) | $11.22 M(+5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | $464.30 K(-95.4%) | $10.68 M(+4.4%) |
| Mar 2015 | - | $10.01 M(+5634.1%) | $10.23 M(+2.1%) |
| Dec 2014 | $10.02 M(+138.3%) | $174.60 K(+487.9%) | $10.02 M(-9.1%) |
| Sept 2014 | - | $29.70 K(+219.4%) | $11.02 M(-8.2%) |
| June 2014 | - | $9300.00(-99.9%) | $12.00 M(-11.5%) |
| Mar 2014 | - | $9.80 M(+730.8%) | $13.56 M(+222.6%) |
| Dec 2013 | $4.20 M(-0.2%) | $1.18 M(+16.9%) | $4.20 M(+20.7%) |
| Sept 2013 | - | $1.01 M(-35.4%) | $3.48 M(+1.7%) |
| June 2013 | - | $1.56 M(+247.4%) | $3.42 M(+15.6%) |
| Mar 2013 | - | $450.00 K(-2.3%) | $2.96 M(-29.7%) |
| Dec 2012 | $4.21 M(+5.0%) | $460.60 K(-51.5%) | $4.21 M(+12.3%) |
| Sept 2012 | - | $950.00 K(-13.6%) | $3.75 M(+33.8%) |
| June 2012 | - | $1.10 M(-35.3%) | $2.80 M(-25.1%) |
| Mar 2012 | - | $1.70 M(>+9900.0%) | $3.74 M(-6.7%) |
| Dec 2011 | $4.01 M(+90.8%) | $0.00(-100.0%) | $4.01 M(-21.6%) |
| Sept 2011 | - | $2200.00(-99.9%) | $5.12 M(-13.5%) |
| June 2011 | - | $2.04 M(+3.7%) | $5.92 M(+51.9%) |
| Mar 2011 | - | $1.97 M(+77.7%) | $3.90 M(+85.4%) |
| Dec 2010 | $2.10 M(+57.4%) | $1.11 M(+37.7%) | $2.10 M(-0.6%) |
| Sept 2010 | - | $804.70 K(+4498.3%) | $2.12 M(+38.7%) |
| June 2010 | - | $17.50 K(-89.9%) | $1.53 M(+1.2%) |
| Mar 2010 | - | $172.50 K(-84.6%) | $1.51 M(+12.9%) |
| Dec 2009 | $1.34 M(-73.9%) | $1.12 M(+424.2%) | $1.34 M(+509.9%) |
| Sept 2009 | - | $214.00 K(>+9900.0%) | $219.00 K(-74.1%) |
| June 2009 | - | $0.00(0.0%) | $845.00 K(-83.2%) |
| Mar 2009 | - | $0.00(-100.0%) | $5.02 M(-2.0%) |
| Dec 2008 | $5.12 M(>+9900.0%) | $5000.00(-99.4%) | $5.12 M(+0.1%) |
| Sept 2008 | - | $840.00 K(-79.9%) | $5.12 M(+19.6%) |
| June 2008 | - | $4.18 M(+4079.6%) | $4.28 M(+4179.6%) |
| Mar 2008 | - | $100.00 K(>+9900.0%) | $100.00 K(>+9900.0%) |
| Dec 2007 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2007 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2006 | $5.08 M | - | - |
| Feb 2006 | - | $1800.00(-100.5%) | $9100.00(+24.7%) |
| Nov 2005 | - | -$393.20 K(-198.2%) | $7300.00(-98.2%) |
| Aug 2005 | - | $400.50 K | $400.50 K |
FAQ
- What is Cytosorbents annual cash flow from financing activities?
- What is the all time high annual CFF for Cytosorbents?
- What is Cytosorbents annual CFF year-on-year change?
- What is Cytosorbents quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cytosorbents?
- What is Cytosorbents quarterly CFF year-on-year change?
- What is Cytosorbents TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cytosorbents?
- What is Cytosorbents TTM CFF year-on-year change?
What is Cytosorbents annual cash flow from financing activities?
The current annual CFF of CTSO is $14.47 M
What is the all time high annual CFF for Cytosorbents?
Cytosorbents all-time high annual cash flow from financing activities is $66.35 M
What is Cytosorbents annual CFF year-on-year change?
Over the past year, CTSO annual cash flow from financing activities has changed by +$9.51 M (+191.84%)
What is Cytosorbents quarterly cash flow from financing activities?
The current quarterly CFF of CTSO is -$99.00 K
What is the all time high quarterly CFF for Cytosorbents?
Cytosorbents all-time high quarterly cash flow from financing activities is $56.38 M
What is Cytosorbents quarterly CFF year-on-year change?
Over the past year, CTSO quarterly cash flow from financing activities has changed by -$747.30 K (-115.27%)
What is Cytosorbents TTM cash flow from financing activities?
The current TTM CFF of CTSO is $21.37 M
What is the all time high TTM CFF for Cytosorbents?
Cytosorbents all-time high TTM cash flow from financing activities is $82.27 M
What is Cytosorbents TTM CFF year-on-year change?
Over the past year, CTSO TTM cash flow from financing activities has changed by +$14.11 M (+194.26%)